Effect on Bleeding Prevention of an Intravenous Proton Pump Inhibitor During the Fasting Period After Endoscopic Submucosal Dissection: a Prospective, Randomized, Double-Blind, Placebo-Controlled Trial
- Authors
- Yoon, Jai Hoon; Kim, Youn Jeong; Lee, Kang Nyeong; Jun, Dae Won; Koh, Dong Hee; Lee, Hang Lak
- Issue Date
- Nov-2020
- Publisher
- SPRINGER
- Keywords
- Endoscopic submucosal dissection; Proton pump inhibitor; Bleeding
- Citation
- JOURNAL OF GASTROINTESTINAL SURGERY, v.24, no.11, pp.2596 - 2601
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF GASTROINTESTINAL SURGERY
- Volume
- 24
- Number
- 11
- Start Page
- 2596
- End Page
- 2601
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/8853
- DOI
- 10.1007/s11605-019-04466-9
- ISSN
- 1091-255X
- Abstract
- Background: No consensus has been achieved on optimal perioperative strategies for patients undergoing endoscopic submucosal dissection (ESD). The aim of this study was to investigate the effects of an intravenous (IV) proton pump inhibitor (PPI) given during the fasting period after ESD on delayed bleeding following ESD.
Methods: This study was designed as a prospective, randomized, double-blind, placebo-controlled trial in a single center. A total of 235 patients who underwent ESD for adenoma and early gastric cancer between March 2016 and September 2018 were randomized into a PPI group and placebo group. Patients were administrated intravenous pantoprazole 40 mg daily (PPI group) or placebo (placebo group) during the fasting period 48 h after ESD (from the day of ESD to the following day, 48 h). After oral feeding (48 h after ESD), oral PPI was given to both groups for 8 weeks.
Results: Among 235 patients in the intention-to-treat (ITT) and 195 in the per-protocol (PP) analysis, there was no significant difference between the PPI and control groups in major bleeding (PPI vs. placebo; 3.3% vs. 1.7%, p = 0.27) or minor bleeding (PPI vs. placebo; 7.6% vs. 4.3%, p = 0.41) after ESD. There was no significant difference in age (p = 0.28), histology (p = 0.75), tumor size (p = 0.48), or procedure time (p = 0.49) between the two groups. The only independent risk factor for major delayed bleeding was the combined use of aspirin and antiplatelet agent (OR; 12.25, 95% CI; 1.06–141.19, p = 0.04).
Conclusions: Administration of routine IV PPI during the fasting period 48 h after ESD does not reduce delayed post-ESD bleeding.
- Files in This Item
-
Go to Link
- Appears in
Collections - 서울 의과대학 > 서울 내과학교실 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/8853)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.